NEW YORK (Reuters Health) – In patients with extensively drug-resistant tuberculosis (XDR TB), adding a later-generation fluoroquinolone to the treatment regimen may improve outcomes, even when drug-susceptibility testing…
NEW YORK (Reuters Health) – When used to prevent postpartum hemorrhage (PPH) following cesarean section, a single dose of carbetocin (Duratocin, Pabal) is less likely than oxytocin (Sintocinon)…
NEW YORK (Reuters Health) – Children receiving the bisphosphonate pamidronate for severe bone demineralization have a prolonged corrected QT interval (QTc), French researchers report online May 25th in…
NEW YORK (Reuters Health) – The extent to which doxycycline slows the progression of knee osteoarthritis (OA) is not the same in neutrally aligned (non-varus) and malaligned (varus,…
NEW YORK (Reuters Health) – A single intravenous (IV) infusion of iron polymaltose added to a standard regimen of oral iron sulfate to treat iron-deficiency anemia in pregnancy…
NEW YORK (Reuters Health) – Preprocedural use of glycoprotein IIb/IIIa inhibitors (GPIs) in primary percutaneous coronary intervention (PCI) after acute myocardial infarction may improve clinical outcomes, according to…
Rafael Barrera, MD, Director of the Surgical Intensive Care Unit at Long Island Jewish (LIJ) Medical Center in New York, explains how human error derived from pharmacy-mixed total…
NEW YORK (Reuters Health) – Despite being recommended by the American Heart Association, there is no evidence that immediate beta-blockade in patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – Combined bivalirudin (Angiomax) and vascular closure devices are better to staunch bleeding after percutaneous coronary intervention (PCI) than either strategy alone, according to…
NEW YORK (Reuters Health) – Oral antiglycemic agents have a modest effect on reducing glycated hemoglobin levels in patients with diabetes, suggests a new systematic review published online…